Skip to main content
logo
IMPACT Therapeutics, Inc (HKG:7630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.60
-1.63 (-12.32%)
Aug 3, 2026, 4:08 PM HKT

IMPACT Therapeutics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Revenue
38.2538.2533.55
Revenue Growth
-14.02%-
Gross Profit
36.6836.6831.99
Operating Income
-233.5-233.5-211.56
Net Income
-295.92-295.92-254.76
Earnings Per Share
-1.29-1.29-1.27
EPS Growth
---

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Chinese Mainland
20.2520.25-
USA
181833.55
Total
38.2538.2533.55

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Cash & Investments
258.53258.53340.19
Total Debt
5.445.446.79
Net Cash (Debt)
253.1253.1333.41
Net Cash Growth
--24.09%-
Net Cash Per Share
1.111.111.66

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Operating Cash Flow
-95.88-95.88-81.31
Capital Expenditures
-1.51-1.51-1.7
Free Cash Flow
-97.39-97.39-83.01
Free Cash Flow Growth
---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Gross Margin
95.89%95.89%95.36%
Operating Margin
-610.43%-610.43%-630.63%
Pretax Margin
-773.63%-773.63%-759.39%
Profit Margin
-773.64%-773.64%-759.40%
FCF Margin
-254.61%-254.61%-247.43%